CN115943140B - 三硫化物化合物 - Google Patents

三硫化物化合物 Download PDF

Info

Publication number
CN115943140B
CN115943140B CN202180050867.6A CN202180050867A CN115943140B CN 115943140 B CN115943140 B CN 115943140B CN 202180050867 A CN202180050867 A CN 202180050867A CN 115943140 B CN115943140 B CN 115943140B
Authority
CN
China
Prior art keywords
pantethine
trisulfide
solution
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202180050867.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN115943140A (zh
Inventor
朝长昌一郎
矶部贵弘
大岛悦男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiehe Pharmaceutical Chemical Co ltd
Original Assignee
Xiehe Pharmaceutical Chemical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiehe Pharmaceutical Chemical Co ltd filed Critical Xiehe Pharmaceutical Chemical Co ltd
Publication of CN115943140A publication Critical patent/CN115943140A/zh
Application granted granted Critical
Publication of CN115943140B publication Critical patent/CN115943140B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202180050867.6A 2020-08-27 2021-08-23 三硫化物化合物 Active CN115943140B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020143639 2020-08-27
JP2020-143639 2020-08-27
PCT/JP2021/030755 WO2022045052A1 (ja) 2020-08-27 2021-08-23 トリスルフィド化合物

Publications (2)

Publication Number Publication Date
CN115943140A CN115943140A (zh) 2023-04-07
CN115943140B true CN115943140B (zh) 2024-10-01

Family

ID=80353266

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180050867.6A Active CN115943140B (zh) 2020-08-27 2021-08-23 三硫化物化合物

Country Status (7)

Country Link
US (1) US12534432B2 (https=)
EP (1) EP4194437B1 (https=)
JP (1) JP7650279B2 (https=)
CN (1) CN115943140B (https=)
ES (1) ES3054285T3 (https=)
PL (1) PL4194437T3 (https=)
WO (1) WO2022045052A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7842033B2 (ja) 2020-05-12 2026-04-07 ザ ジェネラル ホスピタル コーポレイション 神経保護におけるグルタチオントリスルフィド（ｇｓｓｓｇ）
EP4342464A4 (en) 2021-07-08 2025-06-04 Kyowa Pharma Chemical Co., Ltd. PROPHYLACTIC OR THERAPEUTIC MEDICINE FOR PARKINSON'S DISEASE
EP4603087A1 (en) 2022-11-21 2025-08-20 Kyowa Hakko Bio Co., Ltd. Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent
CN120344503A (zh) 2022-12-27 2025-07-18 协和医药化工股份有限公司 三硫化物化合物
WO2025070464A1 (ja) 2023-09-28 2025-04-03 協和ファーマケミカル株式会社 トリスルフィド化合物を含有する医薬組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020158894A1 (ja) * 2019-01-30 2020-08-06 協和発酵バイオ株式会社 ポリスルフィド化合物を含有する組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (https=) * 1973-12-05 1978-02-01
JPS5819673B2 (ja) * 1976-08-26 1983-04-19 相互薬工業株式会社 パンテチンの製造方法
JP2928414B2 (ja) 1991-09-20 1999-08-03 ポーラ化成工業株式会社 皮膚外用剤
SE9402253D0 (sv) * 1994-06-27 1994-06-27 Pharmacia Ab Process
CN107652264A (zh) 2017-09-25 2018-02-02 苏州华诺医药有限公司 硫辛酸杂质a的制备方法
JP2022166333A (ja) * 2019-09-18 2022-11-02 国立大学法人 熊本大学 活性イオウ分子種生体内濃度上昇剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020158894A1 (ja) * 2019-01-30 2020-08-06 協和発酵バイオ株式会社 ポリスルフィド化合物を含有する組成物

Also Published As

Publication number Publication date
JP7650279B2 (ja) 2025-03-24
WO2022045052A1 (ja) 2022-03-03
US20230357141A1 (en) 2023-11-09
ES3054285T3 (en) 2026-02-02
CN115943140A (zh) 2023-04-07
US12534432B2 (en) 2026-01-27
PL4194437T3 (pl) 2026-02-02
EP4194437B1 (en) 2025-11-12
EP4194437A1 (en) 2023-06-14
EP4194437A4 (en) 2024-10-02
JPWO2022045052A1 (https=) 2022-03-03
EP4194437C0 (en) 2025-11-12

Similar Documents

Publication Publication Date Title
CN115943140B (zh) 三硫化物化合物
JP7684315B2 (ja) トリスルフィド化合物及びその包接体
JP4347693B2 (ja) ククルビチュリル誘導体をホスト分子として含む包接化合物およびこれを含む薬剤組成物
TWI733692B (zh) 羧酸取代的(雜)芳環類衍生物及其製備方法和用途
JP7659282B2 (ja) トリスルフィド化合物を用いる、肝細胞増殖因子中のチロシン残基のニトロ化を防止する方法
CN106795175A (zh) 头孢菌素化合物的合成
JP7692465B2 (ja) ペンタフルオロスルファニル基含有アリール化合物の製造方法
TW202019941A (zh) 環丁基嘌呤衍生物或其鹽
WO2004002984A2 (fr) Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
WO2024143231A1 (ja) トリスルフィド化合物及びその包接体
EP4613739A1 (en) Trisulfide compound
KR102207372B1 (ko) 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
WO2026058944A1 (ja) 非対称型のトリスルフィド化合物
AU2006315090B2 (en) Pharmacologically active compounds containing sulfur
AU2005243793A1 (en) Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same
Hwang Disulfide-Cleavable Linkers in Antibody-Drug Conjugates for Targeted Cancer Therapy
US9593052B2 (en) Arsenic complexes for potential diagnostic applications
KR101823271B1 (ko) 신규한 비대칭 상 이동 촉매 및 이를 이용한 알파-아미노산의 제조방법
EP0009996A1 (en) Preparation of vindesine monosulfate
Utsumi et al. [29] Oxidation products of thiamine derivatives
US20200079790A1 (en) Methods of selective aryl- and heteroaryl-nitrogen bond formation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant